13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001801265
Total reported value
$2.3B
$2.3B
20 檔
42.3%
During the Q3 2025 filing period, Madison Avenue Partners, LP (CIK: 0001801265) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $2.3B across 20 reported positions.
In Q3 2025, Madison Avenue Partners, LP adopted a defensive or profit-taking posture, trimming 7 positions and completely liquidating 11 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GHC | Graham Holdings Co-class B | Stock-Industrials | 17.27% | +0.81% | +0.23% | |
| 2 | SNDK | Sandisk CORP | Stock-Tech | 13.81% | -16.15% | -42.24% | |
| 3 | MKL | Markel Group Inc | Stock-Financials | 9.62% | +2.12% | — | |
| 4 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 9.30% | — | -18.41% | |
| 5 | GMED | Globus Medical Inc - A | Stock-Healthcare | 8.71% | +0.49% | +48.83% | |
| 6 | SOLV | Solventum CORP | Stock-Healthcare | 8.66% | +0.45% | -11.40% | |
| 7 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 8.29% | +0.03% | — | |
| 8 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 4.54% | +1.23% | +16.98% | |
| 9 | BTI | British American Tob-sp Adr | Stock-Consumer Staples | 3.88% | -0.09% | — | |
| 10 | WLY | Wiley (john) & Sons-class A | Stock-Other | 2.83% | -1.12% | EXIT | |
| 11 | STGW | Stagwell Inc | Stock-Other | 2.69% | +0.37% | — | |
| 12 | NWSA | News CORP - Class A | Stock-Comm Services | 2.66% | — | — | |
| 13 | KROS | Keros Therapeutics Inc | Stock-Other | 2.56% | -0.01% | +0.62% | |
| 14 | MAGN | Magnera CORP | Stock-Other | 1.98% | — | -15.30% | |
| 15 | AIV | Apartment Invt & Mgmt Co -a | Stock-Other | 1.71% | -0.61% | +145.44% | |
| 16 | CTRI | Centuri Holdings Inc | Stock-Other | 0.88% | — | — | |
| 17 | FSP | Franklin Street Properties C | Stock-Other | 0.25% | -0.03% | EXIT | |
| 18 | NNI | Nelnet Inc-cl A | Stock-Other | 0.24% | — | -78.13% | |
| 19 | ALMS | Alumis Inc | Stock-Other | 0.10% | — | -77.32% | |
| 20 | SN | SharkNinja, Inc. | Stock-Consumer Disc | 0.04% | -0.03% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | INDV | Indivior Pharmaceuticals, Inc. | +3% | -18.41% | Trim |
| 2 | TBPH | Theravance Biopharma, Inc. | +1.1% | — | Unchanged |
| 3 | SN | SharkNinja, Inc. | — | — | Unchanged |
| 4 | FSP | Franklin Street Properties C | -0.2% | — | Trim |
| 5 | STGW | Stagwell Inc | -1% | — | Add |
| 6 | NNI | Nelnet Inc-cl A | -2% | -78.13% | Trim |
| 7 | GHC | Graham Holdings Co-class B | -2.7% | +0.23% | Add |
| 8 | MAGN | Magnera CORP | -3.2% | -15.30% | Trim |
| 9 | MKL | Markel Group Inc | -4.9% | — | Trim |
| 10 | WLY | Wiley (john) & Sons-class A | -5.5% | -42.97% | Trim |
| 11 | SOLV | Solventum CORP | -9.5% | -11.40% | Trim |
| 12 | SNDK | Sandisk CORP | — | NEW | New buy |
| 13 | GMED | Globus Medical Inc - A | — | NEW | New buy |
| 14 | LKFT | Lakefront Biotherapeutic-adr | — | NEW | New buy |
| 15 | BTI | British American Tob-sp Adr | — | NEW | New buy |
| 16 | PCG | P G & E CORP | — | EXIT | Sold out |
| 17 | NWSA | News CORP - Class A | — | NEW | New buy |
| 18 | INVX | Innovex International Inc | — | EXIT | Sold out |
| 19 | KROS | Keros Therapeutics Inc | — | NEW | New buy |
| 20 | SG7 | Sage Therapeutics Inc | — | EXIT | Sold out |
| 21 | AIV | Apartment Invt & Mgmt Co -a | — | NEW | New buy |
| 22 | CTRI | Centuri Holdings Inc | — | NEW | New buy |
| 23 | CMCO | Columbus Mckinnon Corp/ny | — | EXIT | Sold out |
| 24 | ✓ | Acelyrin Inc | — | EXIT | Sold out |
| 25 | CNNE | Cannae Holdings Inc | — | EXIT | Sold out |
| 26 | TSVT* | 2seventy Bio Inc | — | EXIT | Sold out |
| 27 | PLRX | Pliant Therapeutics Inc | — | EXIT | Sold out |
| 28 | ALMS | Alumis Inc | — | NEW | New buy |
| 29 | OVID | Ovid Therapeutics Inc | — | EXIT | Sold out |
| 30 | CRGX | Cargo Therapeutics Inc | — | EXIT | Sold out |
| 31 | ACHC | Acadia Healthcare Co Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Madison Avenue Partners, LP reported a total U.S. public equity portfolio value of $2.3B across 20 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GHC, SNDK, MKL) accounted for 42.3% of total reported equity market value during Q3 2025.
Top New Position Initiated
SNDK
市值: $231.4M
Top Position Liquidated / Trimmed
PCG
前期市值: $50.7M
During Q3 2025, Madison Avenue Partners, LP's top holdings by market value included GHC (17.3%)、SNDK (13.8%)、MKL (9.6%). The largest single position, GHC, represented 17.3% of total portfolio value.
In Q3 2025, Madison Avenue Partners, LP made 29 total portfolio adjustments, initiating 9 new buys, adding to 2 positions, trimming 7 holdings, and fully liquidating 11 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.